These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19101205)

  • 1. Immune barriers to successful gene therapy.
    Wu TL; Ertl HC
    Trends Mol Med; 2009 Jan; 15(1):32-9. PubMed ID: 19101205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How not to be seen: immune-evasion strategies in gene therapy.
    Zaldumbide A; Hoeben RC
    Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of immune responses in gene replacement therapy.
    Ertl HC
    IDrugs; 2005 Sep; 8(9):736-8. PubMed ID: 16118696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivector and antitransgene host responses in gene therapy.
    Hackett NR; Kaminsky SM; Sondhi D; Crystal RG
    Curr Opin Mol Ther; 2000 Aug; 2(4):376-82. PubMed ID: 11249767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
    Bessis N; GarciaCozar FJ; Boissier MC
    Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and strategies: the immune responses in gene therapy.
    Zhou HS; Liu DP; Liang CC
    Med Res Rev; 2004 Nov; 24(6):748-61. PubMed ID: 15250039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral gene therapy.
    von Laer D; Baum C; Protzer U
    Handb Exp Pharmacol; 2009; (189):265-97. PubMed ID: 19048204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered adenovirus serotypes for overcoming anti-vector immunity.
    Dharmapuri S; Peruzzi D; Aurisicchio L
    Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function.
    Chen D; Murphy B; Sung R; Bromberg JS
    Gene Ther; 2003 Jun; 10(11):991-8. PubMed ID: 12756420
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
    Biswas M; Kumar SRP; Terhorst C; Herzog RW
    Front Immunol; 2018; 9():554. PubMed ID: 29616042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.
    Kushwah R; Cao H; Hu J
    Cell Mol Immunol; 2007 Apr; 4(2):81-9. PubMed ID: 17484801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.